Mark Zuckerberg backs $500 million push to build AI models of human cells as part of long-term effort to cure disease.
Morning Overview on MSN
OpenAI launches GPT-Rosalind, a biology-focused model for lab workflows
OpenAI has released GPT-Rosalind, a large language model fine-tuned specifically for life sciences research, marking the company’s most direct push yet into computational biology and drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results